Leishmanicidal, trypanocidal, and cytotoxic activities of endophytic fungi associated with bioactive plants in Brazil

Abstract

One hundred and twenty-one isolates of endophytic fungi were recovered from leaves of the bioactive Brazilian plant species Ageratum myriadenia , Palicourea tetraphylla , Piptadenia adiantoides, and Trixis vauthieri. All fungal isolates were cultivated in liquid media and crude extracts were obtained with ethyl acetate. The crude extracts were tested in bioassay panels using Leishmania amazonensis , Trypanosoma cruzi, the enzyme trypanothione reductase (TryR) from Trypanosoma cruzi, and three human cancer cell lines. Thirty-three extracts (27.2%) exhibited at least one biological activity. Seventeen extracts (14%) were cytotoxic against one or more human cancer cell line with the IC₅₀ values ranged of >0.2 to 25 µg/mL. Twenty-four extracts (19.8%) inhibited the activity of TryR, and three showed ability to inhibit the growth of T. cruzi above 60% and their IC₅₀ values ranged among 1 to 10 µg/mL. Eleven extracts (9%) were able to inhibit the growth of L. amazonensis and showed with IC₅₀ values ranged among 4.6 to 24.4 µg/mL. The endophytic fungi were identified as belonging to the genera Alternaria , Arthrinium , Cochliobolus , Colletotrichum , Penicillium , Fusarium, and Gibberella. An interesting result was obtained for the bioactive isolates UFMGCB 508, 537, 899 and 903, which were related to fungi associated with medicinal plants native to Asia, Australia, Africa, and Polynesia. These results indicate that bioactive plants living in Brazilian ecosystems are a potential host of endophytic fungi able to produce bioactive prototype molecules for drug development against neglected tropical diseases.

INTRODUCTION

Endophytic fungi are found in almost all plants, including trees, grasses, and herbaceous plants. Most endophytic fungi belong to the Ascomycota and their anamorphic stages, which live asymptomatically in plant tissues (12). These fungi have also been recognised as a repository of novel secondary metabolites of pharmaceutical importance. Fifty-one percent of the biologically active substances obtained from these microorganisms were previously unknown (26, 29), and the broad diversity and taxonomic spectrum exhibited by these fungi make them especially interesting for secondary metabolite screening programs.

According to Strobel (29), reasonable hypotheses should govern the plant selection strategy for the discovery of bioactive endophytic fungi; one of these includes plants that exhibit medicinal or pharmacological activities. Recent studies have demonstrated that endophytic fungi living in medicinal plants exert a wide range of biological activities (12, 20). However, there is little information on the fungal endophyte communities associated with bioactive plants living in Brazilian ecosystems. In this study four plants known for their biological activities were selected to endophytic fungi recovered. Palicourea tetraphylla has been used in traditional Brazilian medicine to treat tumours of joints and limbs, and indurations of the prostate (11); Piptadenia adiantoides, popularly known as “Calombi-branco” is used as food and for handcrafting (4); Ageratum myriadenia produce metabolites with cytotoxic and trypanocidal activities (27); and Trixis vauthieri has the ability to produce trixol, a trypanocidal compound active against the protozoan tropical parasite T. cruzi (22).

In previous studies, we showed that the fungi isolated from Brazilian ecosystems are able to produce bioactive secondary metabolites against pathogenic microorganisms (23, 24), Trypanosoma cruzi, and human tumour cells (5, 25). In connection with our program to discover bioactive fungal metabolites, this study focuses on the ability of endophytic fungi recovered from the pharmacological plants A. myriadenia , P. tetraphylla , P. adiantoides, and T. vauthieri to produce secondary metabolites with cytotoxic, leishmanicidal, and trypanocidal activities.

MATERIAL AND METHODS

Sample collection

Plants were collected in the Private Natural Heritage Reserve of the Sanctuary of the Caraça (20º05’S and 43º27’W), which is situated in the Espinhaço Mountain region and includes the biomes Brazilian Savanna (“Cerrado”) and high-altitude plateaus (“Campo de Altitude”) in Minas Gerais state, Brazil. Healthy leaves were collected from Ageratum myriadenia (DC) R.M. King & H. Rob., Palicourea tetraphylla Cham. & Schltdl., Piptadenia adiantoides (Sprengel) Macbr., and Trixis vauthieri DC. The fresh-cut ends of plant samples were were stored in sterile plastic bags and transported under refrigeration to the laboratory over a period of no more than 24 h. All plant vouchers were deposited at the herbarium of the Institute of the Ciências Biológicas (BHCB) of the Universidade Federal of Minas Gerais, Brazil (http://sciweb.nybg.org/science2/IndexHerbariorum.asp).

Fungal isolation

A surface sterilisation method was used, consisting of successive dipping of leaf fragments in 2% Extran (Sigma, USA) detergent (2 min), 70% ethanol (1 min), household bleach with a final sodium hypochlorite concentration of 2% (3 min), and washing with sterile distilled water (2 min). The sterilised fragments were placed on Petri plates containing potato dextrose agar (PDA, Difco, USA) plus chloramphenicol at 100 mg/mL. The plates were incubated up to 60 days, and individual fungal isolates were purified on PDA plates. The isolates were stored at 4°C in PDA tubes. Mycelial fragments from each isolate were also preserved in 30% glycerol sterile aqueous suspension at –80°C. All fungal isolates were deposited in the Collection of Microorganisms and Cells of the Universidade Federal of Minas Gerais, Brazil under code UFMGCB.

Preparation of fungal extracts

The fermentation and crude extract fungi productions for secondary metabolites recovered were previous established by by Rosa et al. (24). Briefly, Pre-inocula for the cultures were prepared by aseptically transferring three 5 mm discs from each microorganism on MEA (2% malt extract, 0.1% peptone, 1.5% glucose, and 1.5% agar) slants into unbaffled 250 mL Erlenmeyer flasks containing 25 mL MEC medium (2% malt extract, 0.1% peptone, 1.5% glucose). The flasks were shaken at 150 r.p.m. and 28°C for five days. The fungal growth of the pre-inoculum flasks was transferred to 250 mL Erlenmeyer flasks containing 100 mL MEC. The inoculated flasks were shaken at 150 r.p.m at 28°C for nine days. After this incubation, the flasks were frozen (-20°C) until extraction. The mycelium was separated from the culture broth by vacuum filtration and the filtrate was extracted with ethyl acetate. After drying with anhydrous sodium sulphate, the solvent was removed in a rotary-evaporator (Büchi model R-114) under vacuum and temperatures below 45°C. The crude extract was further dried in a vacuum centrifuge at 35°C for 24 h and stored at -20°C until assayed. Crude extract stock solutions at 20 mg/mL were prepared in dimetil sulphoxide (DMSO, Meck/USA) and stored at -40°C. These solutions were diluted with water and assayed at the final concentration of 20 µg/mL, with the DMSO concentrations kept below 0.1%.

Assay with Leishmania amazonensis

Promastigotes of Leishmania (Leishmania) amazonensis (strain IFLA/BR/196/PH-8) were obtained from lesions of infected hamsters. The parasites were grown at 26ºC in pH 7.2 Schneider’s medium and then stimulated to differentiate into amastigote-like forms by increasing the temperature (32ºC) and lowering the pH (6.0) of the medium. After seven days under these conditions, 90% of the promastigotes were transformed into amastigote-like forms, which were then used in the bioassays. Amastigote density was adjusted to 1 x 10⁸ parasites per mL, and 90 µL was added to each well of 96-well plates. Ten microliters of compounds and control solutions were added to attain the desired concentrations. The plates were incubated at 32ºC for 72 h, and then cell viability was determined using the MTT (5 mg/mL) assay (31). The results are expressed as percent inhibition in relation to controls without drugs. Amphotericin B at 0.2 µg/mL (Fungison^® Bristol-Myers Squibb B, Brazil) was used as a positive drug control. All assays were performed in triplicate.

Assay with the recombinant enzyme trypanothione reductase (TryR) from Trypanosoma cruzi

The colorimetric assay was performed in 96-well plates according to the protocol established by Hamilton et al. (10). After incubating the enzyme with the samples and controls at 30ºC, Elman’s reagent [5,5’-dithio-bis(2-nitrobenzoic acid)] was added, and the absorbance at 412 nm was measured for 5 min at 12-s intervals. The slope of the curve (ΔAbs/Δt) thus obtained was taken as a measure of enzyme activity, and the percentage of enzyme inhibition was calculated by comparing this value with the slope obtained for controls without drugs. Clomipramine, a known TryR inhibitor (3), was used at 16 µg/mL as a control drug. It has been used as the reference compound against which to compare the potency of newly tested substances. The experiments were repeated twice.

In vitro assay with amastigote intracellular forms of Trypanosoma cruzi

In vitro assay with amastigote forms of T. cruzi was performed according protocols established by Buckner et al. (2) with modifications. Briefly, parasites and culture procedures: T. cruzi (Tulahuen strain) expressing the Escherichia coli β-galactosidase gene were grown on monolayer of mouse L929 fibroblasts. Cultures to be assayed for β-galactosidase activity were grown in RPMI 1640 medium (pH 7.2-7.4) without phenol red (Gibco BRL) plus 10% fetal bovine serum and glutamine. Ninety-six well tissue culture micro plates were seeded with L929 fibroblasts at 4.0 x 10³ per well in 80 μL and incubated overnight. β-galactosidase-expressing trypomastigotes were then added at 4.0 x 10⁴ per well in 20 μL. After 2 h, the medium with trypomastigotes that not penetrated in cells was discarded and replaced by 200 μL of fresh medium. After 48 h, the medium was discarded again and replaced by 180 μL of fresh medium and test compounds in 20 μL. Each extract was tested in triplicate. After 7 days of incubation, chlorophenol red β-D-galactopyranoside (CPRG) (100 mM final concentration) and Nonidet P-40 (0.1% final concentration) were added to the plates and incubated overnight at 37°C and the absorbance measured at 570 nm in an automated micro plate reader. Benzindazole at its IC₅₀ (1 μg/mL) was used as positive control. The results are expressed as percentage growth inhibition.

Assay with human cancer cell lines

The effect of crude extract on the survival and growth of the human cancer cell lines UACC-62 (melanoma), MCF-7 (breast), and TK-10 (renal) was determined using a colorimetric method developed at the National Cancer Institute-USA (17). Briefly, cells were inoculated in 96-well plates and allowed to stabilize for 24 h in a CO₂ incubator at 37°C. Solutions of extracts were added to attain the desired concentrations, and plates were incubated for 48 h under the same conditions. Trichloroacetic acid was added to each well to precipitate the proteins, which were quantified in a colorimetric assay using the dye sulphorodamine B. All assays were run in triplicate wells and repeated at least once. Etoposide at 16 µg/mL and cancer cell lines without fungal extracts were used in parallel as positive and negative controls, respectively. Results are expressed as percentage of growth inhibition in comparison to the control without drug.

Statistical analysis

The software GraphPad Prism version 4.03 was used to calculate the IC₅₀ values using the non-linear curve fitting of two or more independent experimental datasets to a four parameter logistic dose-response model. No constraints were applied to the curve fitting calculations.

DNA extraction, amplification and sequencing

For DNA extraction, approximately 1.5 cm of mycelium growth was transferred to 2 mL sterile tubes (Eppendorf) with 400 µL of extraction buffer solution (0.05 M Tris-HCl, 50 mM Na-EDTA, 1 mM NaCl, and 1% SDS), frozen at -20°C overnight, and triturated vigorously. After adding 5 µL of proteinase K (Sigma-Aldrich/USA), the material was shaken and incubated for 12 h at 37°C. After incubation, 162 µL of CTAB-Buffer (200 mM Tris HCl, pH 7.5; 200 mM Na-EDTA, 8.2% NaCl, 2% CTAB) was added, and the mixture was vortexed vigorously and incubated for 10 min in 65°C. Chloroform/isoamilic alcohol (24:1; 570 µL) was added, then the mixture was vortexed vigorously, incubated for 30 min at 0°C, and centrifuged for 10 min at 14,000 r.p.m. After transferring the aqueous supernatant (approximately 400 µL) to a new 1.5 mL Eppendorf tube, 40 µl of 3 M sodium acetate was added and incubated for 1.5 min at 0°C, and centrifuged for 10 min at 14,000 r.p.m. The supernatant was transferred to a new 1.5 mL Eppendorf tube, and 50% isopropyl alcohol was added, centrifuged for 5 min at 14,000 r.p.m., and the supernatant discarded. The pellet was washed twice with 200 µL 70% ethanol at 10°C. DNA was dried overnight at room temperature, suspended in TE-buffer (10 mM Tris, 10 mM Na-EDTA, pH 8.0), incubated for 60 min at 65°C, and stored in a refrigerator.

The ITS domains of rRNA gene were amplified with the universal primers ITS1 (5´-TCCGTAGGTGAACCTGCGG-3´) and ITS4 (5´-TCCTCCGCTTATTGATATGC-3´) as described by White et al. (33). Amplification of ITS were performed as follows: 95ºC for 5 min, followed by 39 cycles consisting of 94ºC for 60 s, 50ºC for 60 s, and 72ºC for 60 s, and a final extension at 72ºC for 5 min. The amplified DNA was concentrated, cleaned using the kit Wizard Plus SV Minipreps DNA Purification System (Promega, USA), and sequenced in a MegaBACE^TM 1000 automated sequencing system (Amersham Biosciences, USA). The sequences obtained were adjusted using SeqMan Π of Lasergene software (DNASTAR/Inc.), and a consensus sequence was obtained using the software Bioedit v. 7.0.5.3. To reach species level identification by rRNA gene sequencing, the consensus sequence was aligned with all sequences of related species retrieved from GenBank database using the Fasta 2.0 program (1). After sequencing, the consensus sequences were deposited in GenBank under the accession numbers FJ466701 to FJ466730. Phylogenetic relationships were estimated using MEGA program Version 4.0 (30). The phylogenetic trees were constructed using the neighbour joining (NJ) algorithm with bootstrap values calculated from 1,000 replicate runs. The Maximum Composite Likelihood model was used to estimate evolutionary distance.

RESULTS AND DISCUSSION

In this study, crude extracts of 121 fungal endophytes were obtained from four pharmacological plants present in Brazilian ecosystems, which were tested in different biological assay models. Eight bioactive isolates were recovered from A. myriadenia, 10 from P. tetraphylla, 10 from P. adiantoides, and five from T. vauthieri (Table 1). Thirty-three extracts (27.2%) exhibited at least one biological activity. Among the active extracts, 17 (14%) inhibited cellular growth by more than 60% for one or more human cancer cell lines. The extracts from endophytic isolates UFMGCB 508, 523, 533, 536, and 554 exhibited 100% inhibition against all tumour cell lines tested. Fungal extracts from UFMGCB 540, 899, and 903 isolates were active only against the tumour cells. The extracts that showed cytotoxic activities ≥90% were tested to determine the IC₅₀ values, which ranged of >0.2 to 25 µg/mL (Table 4). The extracts that showed selective activities against tumoral cells and the best IC₅₀ values (>2 µg/mL) will be selected to isolation of their bioactive compounds.

Table 1.

Fungal crude extracts which biological activities above 60% when tested at 20 µg/mL against human tumour cells, the recombinant enzyme trypanothione reductase (TryR), and amastigote forms of the Leishmania amazonensis.

Host plant	aUFMGCB	Growth inhibition of human tumor cells (%)			Inhibition of eTryR (%)	Kill of Leishmania amazonensis (%)
		bUACC-62	cMCF-7	dTK-10
Palicourea tetraphylla Cham. & Schltdl.	508	100	100	100	99	70
	509	43	34	49	92	88
	513	11	10	8	74	63
	517	16	9	6	79	52
	518	12	36	35	99	14
	521	18	15	18	70	47
	523	100	100	100	100	57
	525	12	16	10	73	20
	529	96	98	100	2	90
	531	17	11	15	70	8
Piptadenia adiantoides (Sprengel) Macbr.	532	18	8	15	91	51
	533	100	100	100	78	0
	534	15	17	12	82	45
	535	100	100	57	84	0
	536	100	100	100	94	0
	537	54	87	100	98	36
	538	19	15	17	78	4
	540	57	57	100	7	28
	553	25	100	17	10	72
	554	100	100	100	12	87
Ageratum myriadenia Sch. Bip. ex. Baker	563	100	100	92	100	60
	564	57	88	95	44	57
	568	100	100	59	99	52
	569	30	28	6	92	1
	579	34	43	27	60	86
	648	100	100	96	78	78
	652	18	14	4	97	0
	654	38	41	16	93	0
Trixis vauthieri DC	899	43	66	84	17	14
	903	73	96	94	32	0
	908	56	35	17	87	56
	910	100	90	67	6	92
	914	27	18	10	7	80
Positive controls	Etoposide	83	80	44.5	-	-
	Clomipramine	-	-	-	72.5	-
	Amphotericin B	-	-	-	-	71

^aUFMGCB = Collection of Microorganisms and Cells of the Universidade Federal of Minas Gerais.

^bUACC-62 = melanoma,

^cMCF-7 = mammary, and

^dTK-10 =kidney.

^eTryR = recombinant enzyme trypanothione reductase from Trypanosoma cruzi.

Table 4.

IC₅₀ values of selected bioactive endophytic fungal extracts (tested in µg/mL).

Crude extract	aUFMGCB	Growth inhibition of human tumor cells (IC50)	Kill of Trypanosoma cruzi (IC50)	Kill of Leishmania amazonensis (IC50)
		bUACC-62	cMCF-7	dTK-10
3645	508	5	1.5	2	>1	ent
3686	529	6.3	8	12.5	nt	9.8
3693	533	1	<0.2	1	10	nt
3695	534	nt	<0.2	nt	nt	nt
3697	535	1	nt	nt	10	nt
3699	536	1.2	<0.2	1	10	nt
3700	537	nt	nt	20	nt	nt
3736	554	1.5	<0.2	1.2	nt	24.4
3966	563	20	8	20	nt	nt
3967	564	nt	nt	1.5	nt	nt
3968	568	1.6	20	nt	nt	nt
3971	579	nt	nt	nt	nt	4.6
4013	648	10	4	1.3	nt	nt
4023	903	nt	<0.2	25	nt	nt
4031	914	nt	nt	nt	nt	20
	Etoposide	16	16	16	nt	nt
	Amphotericin B	nt	nt	nt	nt	0.2
	Benznidazole	nt	nt	nt	1	nt

^aUFMGCB = Collection of Microorganisms and Cells of the Universidade Federal of Minas Gerais;

^bUACC-62 = melanoma;

^cMCF-7 = mammary;

^adTK-10 = kidney;

^ent = not tested.

Twenty-four (19.8%) fungal extracts inhibited by more than 60% the activity of TryR, a key enzyme that helps Trypanosoma and Leishmania parasites to maintain a reducing intracellular environment by reducing its natural substrate trypanothione disulphide (10), and is a potential target for trypanocidal and leishmanicidal drugs. The highly selective activities of isolates UFMGCB 518, 525, 531, 538, and 569 against TryR suggest the presence of trypanocidal compounds in the extracts of these fungi. The extracts that showed actives ≥90% in TryR assays were tested against T. cruzi (Table 2). Among these, three extracts produced by endophytic isolates UFMGCB 508, 533, and 536 showed abilities to inhibit more or equal 60% the growth of T. cruzi. The IC₅₀ of these extracts were determinate and ranged of 1 to 10 µg/mL (Table 4). The best crude extract was produced by the endophytic isolate UFMGCB 508 with activity of 1 µg/mL, the same value of drug control benznidazole and will be selected to isolation of trypanocidal compounds.

Table 2.

Fungal crude extracts active (≥90%) against the recombinant enzyme trypanothione reductase (TryR) and tested against amastigote forms of Trypanosoma cruzi.

aUFMGCB code	Inhibition of bTryR (%)	Kill of Trypanosoma cruzi (%)
508	99	90
518	99	0
523	100	27
532	91	0
533	90	62
536	94	60
537	98	25
563	100	0
568	99	0
654	93	0
Clomipramine	72.5	-
Benznidazole	-	73

^aUFMGCB = Collection of Microorganisms and Cells of the Universidade Federal of Minas Gerais.

^bTryR = recombinant enzyme trypanothione reductase from Trypanosoma cruzi.

Extracts of isolates UFMCB 508, 509, 513, 529, 563, 579, and 648 inhibited TryR and were active against amastigote forms of L. amazonensis. Isolate UFMGCB 908 was obtained from the trypanocidal plant T. vauthieri and inhibited TryR activity by 87%. Eleven (9%) fungal endophyte extracts were able to inhibit the growth of amastigote forms of L. amazonensis more than 60%. Two fungal extracts obtained from isolates UFMGCB 529 and 910 inhibited the growth of L. amazonensis by more than 90%. The best active extracts were submitted to IC₅₀ determination, which range of 4.6 to 24.4 µg/mL (Table 4). Isolate UFMGCB 914 was able to produce a crude extract with highly selective leishmanicidal activity. All leishmanicidal extracts will be submitted to isolation of bioactive compounds.

All bioactive endophytic fungi recovered from leaves of bioactive plants did not produce conidia or spores (mycelia sterilia) in common mycological media tested (malt extract agar, potato dextrose agar, and Sabouraud’s dextrose agar). According Phongpaichit et al. (20) the most of endophytic fungi did not produce sexual or asexual microstructures in culture media and only could be identified by molecular methods. Thus, our strategy was to identify these mycelia sterilia by means of rRNA gene sequence comparison (assessment of percentage nucleotide identities with reference sequences) as well as phylogenetic analysis. In this work, fungal molecular identification based on ITS sequence analysis revealed that the most active isolates belong to Arthrinium Kunze (12 isolates), Penicillium Link (four isolates), Gibberella Sacc. (three isolates), Uncultured fungus (three isolates), Endophytic fungi (three isolates), Alternaria Nees, Fusarium Link ex Gray, Cochliobolus, and Colletotrichum Corda, each with one isolate (Table 3).

Table 3.

Molecular identification based on sequencing of ITS region of endophytic fungi able to produce bioactive metabolites.

UFMGCBa code	Closest related species/GenBank accession number	Maximum identity (%)	Identification	GenBank accession number
563	Alternaria arborescens [AY154706]	98	A. arborescens	FJ466719
513	Arthrinium sp. [AJ279479]	93	Arthrium sp.	FJ466703
521	Arthrinium sp. [AJ279479]	93	Arthrium sp.	FJ466706
509	Arthrinium sp. [AM901699]	93	Arthrium sp.	FJ466702
517	Arthrinium sp. [AM922206]	96	Arthrium sp.	FJ466704
525	Arthrinium sp. [AM922206]	98	Arthrium sp.	FJ466708
531	Arthrinium sp. [AM922206]	100	Arthrium sp.	FJ466710
532	Arthrinium sp. [AM922206]	98	Arthrium sp.	FJ466711
534	Arthrinium sp. [AM922206]	99	Arthrium sp.	FJ466713
535	Arthrinium sp. [AM922206]	99	Arthrium sp.	FJ466714
908	Arthrinium sp. [AM922206]	100	Arthrium sp.	FJ466728
911	Arthrinium sp. [AM922206]	97	Arthrium sp.	FJ466729
538	Arthrinium sp. [AM922206]	98	Arthrium sp.	FJ466717
564	Bipolaris zeicola [FJ213843]	95	Bipolaris sp.	FJ466720
554	Cochliobolus melinidis [AF071319]	89	Endophytic fungus.	FJ466718
611	Colletotrichum boninense [EU822802]	98	C. boninense	FJ466723
914	Fungal endophyte [EU687084]	92	Endophytic fungus	FJ466730
899	Fungal endophyte [EU687163]	99	Endophytic fungus	FJ466726
903	Fungal endophyte [EU687185]	95	Endophytic fungus	FJ466727
529	Fusarium oxysporum [DQ535184]	99	F. oxysporum	FJ466709
533	Gibberella sp. [EU552131]	99	Gibberella sp.	FJ466712
536	Gibberella sp. [EU552131]	99	Gibberella sp.	FJ466715
648	Gibberella sp. [EU552131]	97	Gibberella sp.	FJ466724
518	Penicillium citrinum [DQ123646]	99	P. citrinum	FJ466705
579	P. citrinum [DQ123646]	97	P. citrinum	FJ466722
654	P. dipodomyicola [DQ339570]	98	P. citrinum	FJ466725
523	P. griseofulvum [FJ011548]	99	P. griseofulvum	FJ466707
508	Uncultured fungus [AJ877196]	97	Endophytic fungus	FJ466701
537	Uncultured fungus [AJ877196]	98	Endophytic fungus	FJ466716
568	Uncultured fungus [EF505005]	98	Endophytic fungus	FJ466721

^aUFMGCB = Collection of Microorganisms and Cells of the Universidade Federal of Minas Gerais.

Eleven isolates were identified as species belonging to the genus Arthrinium, which includes species described as producers of secondary metabolites with biological activities such as arthrichitin and CAF-603 (antifungal), terpestacin (cytotoxic), and the xanthone derivative norlichexanthone (antioxidant) (21). Arthrinium species are found as phytopathogens, opportunists, or endophytic fungi. Nine isolates were similar to Arthrinium sp. (GenBank accession number AM922206), a strain recovered from the perennial grass Dactylis glomerata (Poaceae) which is native to the temperate zones of Europe and Asia (16), and was used in folk medicine against cancer (8). Four isolates were more than 97% identical to Penicillium species, and identified as P. citrinum UFMGCB 518, Penicillium sp. UFMGCB 523, Penicillium sp. UFMGCB 579, and P. dipodomyicola UFMGCB 654. Penicillium species can be pathogens, saprobes, opportunists, or endophytes of plants in natural environments (20), and many species of this genus produce different groups of bioactive secondary metabolites (32). The ITS regions of isolates UFMGCB 533, 536, and 648 exhibited more than 99% identity to Gibberella sp. (GenBank accession number EU552131) and the isolate UFMGCB 529 was 99% identical to Fusarium oxysporum (GenBank accession number DQ535184). Gibberella species are plant pathogens, although many are more familiar under their Fusarium anamorph names, which are the most commonly reported endophytes of wild plants (14). The complex Gibberella/Fusarium species produce several biologically active metabolites such as fusaric acid, moniliformin, fumonisins, zearalenon, enniatins, trichothecenes, and others (7).

The ITS regions of isolates UFMCB 554 and UFMGCB 564 were 95% and 89% identical to Bipolaris zeicola and Cochliobolus melinidis, respectively. The genus Bipolaris (anamorphous of Cochliobolus) contains about 45 species which are mostly subtropical and tropical plant parasites; in this study, these two genera were found as endophytes in healthy tissues of P. adiantoides. Some bioactive natural products were isolated from Bipolaris/Cochliobolus species. Different species of Cochliobolus and Bipolaris produce phytoxin ophiobolins (34). Isolate UFMGCB 611 had 98% identity with Colletotrichum boninense (GenBank accession number EU822802). Inácio et al. (13) recovered C. gloeosporioides from leaves of Cryptocarya mandioccana Nees (a Brazilian Atlantic Forest plant species), which was able to produce antifungal metabolites against phytopathogenic fungi. Colletotrichum species recovered from Artemisia annua (15) and Palicourea longiflora leaves (27) are antimicrobial metabolites producer. Isolate UFMGCB 563 was 98% identical in the ITS region with Alternaria arborescens (GenBank accession number AY154706). Species of Alternaria can be found as endophytic fungi in different plant species (6), and are able to produce about 70 bioactive secondary metabolites (18).

The ITS regions of three isolates matched best with uncultured clone fungi: isolates UFMGCB 508, 537, and 568 were similar to uncultured fungi. An interesting result was obtained for the isolates UFMGCB 508 and UFMGCB 537, which exhibited 97% and 98% identity, respectively, with an Uncultured fungus (GenBank accession number AJ877196) that was recovered from leaves of the Heterosmilax japonica Kunth, known pharmaceutical plant used in Chinese traditional medicine (9). The phylogenetic analysis of the isolates UFMGCB 508 and 537 showed only seven (1.4%) and one (0.2%) nucleotide differences in the ITS region, respectively, when compared to the Uncultured fungus (GenBank accession number AJ877196) from the H. Japonica (Figure 1). The isolate UFMGCB 568 present showed 98% sequence identity and five (1%) nucleotide differences in the ITS region to an Uncultured endophytic fungus (GenBank accession number EF505005) recovered from Zea mays (maize) (19).

Figure 1.

Evolutionary tree showing the relationships among Endophytic fungi isolates UFMGCB 508, 537, and 568 and the next fungal sequences present in GenBank databases. The tree was constructed based on the rRNA gene sequence (ITS1-5.8S-ITS2) fragment sequence by using the neighbor-joining method. The numbers represent the percentage of 1,000 bootstrap replications in which a given branch appeared. The tree was rooted by making Trametes versicolor [AF042324] as outgroup.

Isolates UFMGCB 899, 903, and 914 were related to three Unidentified endophytic fungi (identities ranging of 92 to 99%) recovered in tropical grasses with GenBank accession numbers EU687163, EU687084, and EU687185, respectively. However, the isolate UFMCB 899 showed 96% identities in the ITS region to Xylaria sp. D61 (GenBank accession number EU099587) recovered from leaves of Garcinia dulcis Kurz., native to Asia, Australia, Africa, and Polynesia, which showed antibacterial, antimalarial, cytototicity, and antiproliferation activities (20). The isolate UFMGCB 903 presented 97% identity and in phylogenetic analysis (Figure 2) eight (1.7%) nucleotides difference in ITS rRNA gene sequences with Xylaria sp. S20 (GenBank accession number EU678657) an endophytic fungus recovered from Dendrobium nobile Lindl. a famous Chinese traditional medicinal orchid (35). The taxonomic position of the bioactive isolates UFMGCB 540, 553, 569, and 910 could not be determined by ITS sequences, and further taxonomic studies will be conducted to determine their taxonomic positions.

Figure 2.

Evolutionary tree showing the relationships among Endophytic fungi isolates UFMGCB 899, 903, and 914 and the next fungal sequences present in GenBank databases. The tree was constructed based on the rRNA gene sequence (ITS1-5.8S-ITS2) fragment sequence by using the neighbor-joining method. The numbers represent the percentage of 1,000 bootstrap replications in which a given branch appeared. The tree was rooted by making Trametes versicolor [AF042324] as outgroup.

The results from this study have clearly confirmed the high diversity of endophytic fungi producing bioactive compounds in these bioactive plants living in Brazilian biomes. Endophytic fungi obtained from plants A. myriadenia , P. tetraphylla , P. adiantoides, and T. vauthieri could be a promising source of antitumoral, leishmanicidal, and trypanocidal prototype secondary metabolites, which could be a pipeline for the development of new drugs. The promising crude extract, which showed the best IC₅₀ values and selective activities, will be selected to isolation of actives compounds.